Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Centers for Disease Control and Prevention, under the Department of Health and Human Services, is seeking research proposals to identify and evaluate potential risk factors for Amyotrophic Lateral Sclerosis. The initiative encourages studies focused on military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents or environmental exposures linked to ALS. Funding is available through four distinct options: Option A supports research with strong existing evidence, including studies that refine prior findings or connect risk factors to diagnosis and treatment; Option B funds new and exploratory research on under-investigated risk factors or those employing novel methodologies; Option C targets ALS risk in specific populations, particularly military veterans, to better understand disparities and unique exposures; and Option D is dedicated to analyzing biological samples from the Guamanian ALS cluster to uncover disease mechanisms, exposure pathways, genetic influences, and biomarkers with potential for developing diagnostics, therapeutics, or prevention strategies. All proposals must align with these priorities and be submitted through the designated grant portal. The opportunity was posted on July 8, 2026, and inquiries can be directed to Dr. Candis Hunter at the provided email and phone number. There is no set-aside designation or NAICS code specified, and the performance location is not limited to a specific geographic area. Researchers are encouraged to apply regardless of prior federal funding experience, as long as their work addresses one of the four funding options with scientific rigor and relevance to ALS etiology and public health impact.

General Info

CDC seeks ALS risk factor research focusing on military, sports, trauma, neuroinflammation, and environmental exposures across four funding options.

Agency

Department Of Health And Human Services → Centers For Disease Control And PreventionView Agency

NAICS

N/A

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Centers For Disease Control And Prevention
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → Centers For Disease Control And Prevention
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.